http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107445963-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-42 |
| filingDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107445963-B |
| titleOfInvention | A kind of quinoxaline derivatives and its preparation method and application |
| abstract | The invention discloses a kind of quinoxaline derivatives, shown in the structural formula of the quinoxaline derivatives such as formula (Ι) or formula (II), the present invention discloses the preparation method of the quinoxaline derivatives and its application in preparations of anti-tumor drugs.Quinoxaline derivant provided by the present invention can be intracellular with novel targets-vimentin vimentin interaction, inhibit tumor cell proliferation and migration, can be applied to the exploitation of new type antineoplastic medicine.It is highly-safe in the application for preparing anticancer drug simultaneously to normal cell small toxicity, and the quinazoline derivant all has a strong inhibitory effect kinds of tumor cells, has very high medical value and vast market prospect on preparing anticancer drug. |
| priorityDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.